[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@lindendoss lindenMD

lindenMD posts on X about $nktr, $agio, agio, $rzlt the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

Engagements: undefined #

• X Week XXX -XX%
• X Month XXXXX +138%
• X Months XXXXX +14,335%
• X Year XXXXX -XX%

Mentions: undefined #

• X Months XX +1,300%
• X Year XX -XX%

Followers: XXX #

• X Week XXX +0.85%
• X Month XXX +7.40%
• X Months XXX +35%
• X Year XXX +33%

CreatorRank: undefined #

Social Influence

Social topic influence $nktr 28.57%, $agio 28.57%, agio 28.57%, $rzlt 14.29%, at least XXXXX%

Top accounts mentioned or mentioned by @canoebrookbl @seedy19tron @tradingsssss @researchpulse1 @bioinvestor24 @rnflex @duartesatirico @doctorsalomon @btcbabey @investorclimber @hscottmatusow

Top assets mentioned Agios Pharmaceuticals, Inc. (AGIO)

Top Social Posts

Top posts by engagements in the last XX hours

"@tradingsssss im waiting on the sidelines for $nktr readout. true believer in AD but AA too messy a binary for me and guaranteed to drop if it misses. $agio $rzlt better short term catalysts"
X Link 2025-11-29T22:33Z XXX followers, 1320 engagements

"Id say. as someone who loves $nktr for AD. For AA stock is not de-risked at ALL. 1/3 chance to +50% if it hits 2/3 chance to - XX% (at LEAST) if miss EV is DEFINITELY negative look at what just happened to $agio X weeks ago. good data on thalassemia dz. but missed sickle cell primary endpoint (pain) even though it hit other primary endpoint (hemoglobin) stock -XX% immediately. not a fan of those odds to hold stock short term. i bought the $agio dip and now up XX% in a week. probably will dump into fda decision. smarter to do the same with $nktr. stock will continue to trend up after the"
X Link 2025-11-29T23:26Z XXX followers, 1381 engagements